A cause of falsely low HDL concentrations in HIV-infected patients: Increased polyclonal serum immunoglobulin

Clinical Biochemistry

Volumn 38, Issue 1, 2005, Pages 46-49

  Zapico Muñiz, Edgar ^a   Jorba Castany, Oscar ^a   Bonet Marqués, Rosa ^a   Ordoñez Llanos, Jordi ^a,b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Direct HDLc method; HIV patients; Polyclonal hypergammaglobulinemia

Indexed keywords

ANTIRETROVIRUS AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN; PHOSPHOTUNGSTIC ACID; REAGENT;

ABSORPTION; ARTICLE; DENSITY; ELECTROPHORESIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGAMMAGLOBULINEMIA; PRECIPITATION; PRIORITY JOURNAL; ULTRACENTRIFUGATION;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHOLESTEROL, HDL; HIV INFECTIONS; HUMANS; IMMUNOGLOBULINS;

EID: 10644295761     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2004.09.010     Document Type: Article

References (11)

1. S.A. Riddler, E. Smit, and S.R. Cole Impact of HIV infection and HAART on serum lipids in men JAMA 89 2003 2978 2982
2. L. Hunziker, M. Recher, and A.J. Macpherson Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections Nat. Immunol. 4 2003 343 349
3. M.P. Dubé, D. Sprecher, W.K. Henry Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group CID 31 2000 1216 1224
4. National Cholesterol Education Program Expert Panel Third report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (ATPIII) NIH Publication 2001 National Heart, Lung, and Blood Institute Bethesda
5. G.R. Warnick, M. Nauck, and N. Rifai Evolution of methods for measurement of HDL-cholesterol: from ultracentrifugation to homogeneous assays Clin. Chem. 47 2001 1579 1596
6. H. Sugiuchi, Y. Uji, and H. Okabe Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated α-cyclodextrin Clin. Chem. 41 1995 717 723
7. M.F. Lopes-Virella, P. Stone, S. Ellis, and J.A. Colwell Cholesterol determination in high-density lipoproteins separated by three different methods Clin. Chem. 23 1977 882 884
8. T. Kazumi, A. Kawaguchi, and T. Hozumi Low density lipoprotein particle diameter in young, nonobese, normolipidemic Japanese men Atherosclerosis 142 1999 113 119
9. G. Shor-Posner, A. Basit, and Y. Lu Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection Am. J. Med. 94 1993 515 519
10. N. Kadri, P. Douville, and P. Lachance Monoclonal paraprotein may interfere with the Roche direct HDL-c Plus assay Clin. Chem. 48 2002 964
11. F. Pontet, X. Gué, M.C. Mazeron, S. Alain, and M.J. Sanson-Le Pors Qualitative immunoglobulin abnormalities in HIV-positive patients: long-term follow up Clin. Chem. Lab. Med. 35 1998 493 496